Zhiqian Lucy Liu
About Zhiqian Lucy Liu
Zhiqian Lucy Liu serves as the Senior Director and Head of Analytics at Alloy Therapeutics, Inc., a position she has held since 2021. She has extensive experience in the biotechnology field, having previously worked in various roles at companies such as Compass Therapeutics LLC, Biogen Idec, and Dana-Farber Cancer Institute.
Current Role at Alloy Therapeutics
Zhiqian Lucy Liu serves as the Senior Director and Head of Analytics at Alloy Therapeutics, Inc. since 2021. In this role, she oversees analytics initiatives, contributing to the company's mission in therapeutic development. Her leadership in analytics is pivotal for advancing the company's research and development efforts.
Previous Experience at Alloy Therapeutics
Before her current position, Zhiqian Liu worked at Alloy Therapeutics, Inc. as the Director and Head of Protein Analytics from 2020 to 2021. During her tenure, she focused on protein analytics, enhancing the company's capabilities in this area. Her experience in this role laid the groundwork for her current responsibilities.
Career at Compass Therapeutics
Zhiqian Liu held multiple positions at Compass Therapeutics LLC. She served as Associate Director from 2018 to 2020, where she contributed to various projects. Additionally, she was the Principal Scientist from 2016 to 2018 and briefly worked as Director of High-Throughput Characterization in 2020. Her roles at Compass Therapeutics involved significant contributions to therapeutic development.
Postdoctoral Research and Early Career
Zhiqian Liu began her career in academia as a Post-Doctoral Fellow at Dana-Farber Cancer Institute and Harvard Medical School from 2006 to 2010. She later worked as a Post-Doctoral Scientist at EMD Serono from 2010 to 2011. These positions provided her with foundational research experience in cancer biology and antibody technologies.
Educational Background in Biochemistry
Zhiqian Liu earned her Ph.D. in Biochemistry from McGill University. Her educational background has equipped her with a strong foundation in biochemical research, which has been instrumental throughout her career in the biotechnology and pharmaceutical industries.